Resmed Inc’s recent filing unveils that its Chief Financial Officer Sandercock Brett unloaded Company’s shares for reported $0.24 million on Jan 02 ’26. In the deal valued at $241.75 per share,1,000 shares were sold. As a result of this transaction, Sandercock Brett now holds 86,495 shares worth roughly $21.55 million.
Then, Rider Michael J sold 50 shares, generating $12,088 in total proceeds. Upon selling the shares at $241.75, the Global General Counsel now owns 9,741 shares.
Before that, Sandercock Brett bought 1,000 shares. Resmed Inc shares valued at $241,750 were divested by the Officer at a price of $241.75 per share.
Robert W. Baird downgraded its Resmed Inc [RMD] rating to a Neutral from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. CLSA also remained covering RMD and has increased its forecast on September 02, 2025 with a “an Outperform” recommendation from previously “Hold” rating. RBC Capital Mkts revised its rating on July 15, 2025. It rated RMD as “an Outperform” which previously was an “a Sector perform”.
Price Performance Review of RMD
On Tuesday, Resmed Inc [NYSE:RMD] saw its stock jump 1.56% to $249.19. Over the last five days, the stock has gained 2.61%. Resmed Inc shares have risen nearly 9.06% since the year began. Nevertheless, the stocks have risen 3.45% over the past one year. While a 52-week high of $293.81 was reached on 01/06/26, a 52-week low of $199.92 was recorded on 01/02/26.
Levels Of Support And Resistance For RMD Stock
The 24-hour chart illustrates a support level at 245.08, which if violated will result in even more drops to 240.96. On the upside, there is a resistance level at 251.73. A further resistance level may holdings at 254.26.
How much short interest is there in Resmed Inc?
A steep rise in short interest was recorded in Resmed Inc stocks on 2025-12-15, dropping by 90039.0 shares to a total of 10.56 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 10.65 million shares. There was a decline of -0.85%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 19, 2025 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating along with a $280 price target.
